Rivus Pharmaceuticals
PrivateLast Round
Series B
Sep 22, 2022
Total Funding Raised
$167M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Rivus Pharmaceuticals operates in Healthcare & Life Sciences and is based in Charlottesville, Virginia. Its latest recorded funding round was a Series B round in September 2022.
Rivus Pharmaceuticals is a biopharmaceutical company that develops controlled metabolic accelerators aimed at enhancing cardio-metabolic health through oral small-molecule therapeutics targeting the root causes of metabolic and cardiovascular diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Rivus Pharmaceuticals Comparables
Compare Rivus Pharmaceuticals with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| OrsoBio | 85% | |
| Roche Holding | 82% | |
| Terns Pharmaceutical | 81% |
For institutional investors. Book with your work email.
Rivus Pharmaceuticals Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Sep 22, 2022 | ||||
| Series A | Jul 20, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Rivus Pharmaceuticals Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Longitude Capital | Series B, Series A |
| Bain Capital Life Sciences | Series B |
| RA Capital Management | Series B |
| BB Biotech | Series B |
| Medicxi | Series B, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 28, 2026
Monthly visitors increased 53% MoM, reaching 4.2K.
- Jun 19, 2026
Monthly visitors increased 114% MoM.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- attends_eventOct 19, 2026
Rivus Pharmaceuticals, Inc. attends The Obesity Society's 44th Annual Meeting at ObesityWeek(R) 2026 in District of Columbia in Nov '26 and presents preclinical obesity data for RV-8451.
- attends_eventOct 19, 2026
Rivus Pharmaceuticals, Inc. plans to present preclinical obesity data on muscle-preserving oral GLP-1 RV-8451 at ObesityWeek in District of Columbia on Nov 14-17, 2026.
For institutional investors. Book with your work email.
Rivus Pharmaceuticals Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Rivus Pharmaceuticals's valuation, stock price, and market status.
Is Rivus Pharmaceuticals a public or private company?
Rivus Pharmaceuticals is a private company.
What is the current stock price of Rivus Pharmaceuticals?
Rivus Pharmaceuticals is a private company, so its shares have no public market price. Caplight tracks Rivus Pharmaceuticals's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Rivus Pharmaceuticals worth (valuation)?
Valuation information for Rivus Pharmaceuticals is not publicly available.
Can I buy Rivus Pharmaceuticals stock?
Rivus Pharmaceuticals shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Rivus Pharmaceuticals's last funding round?
Rivus Pharmaceuticals's most recent funding round was Series B on September 22, 2022.
Who are the main investors in Rivus Pharmaceuticals?
Key investors in Rivus Pharmaceuticals include Longitude Capital, RA Capital Management, Medicxi.
Will Rivus Pharmaceuticals IPO soon?
No public IPO plans have been announced for Rivus Pharmaceuticals.
How can I track Rivus Pharmaceuticals secondary market activity?
Caplight tracks bids, offers, and trades in Rivus Pharmaceuticals's shares on secondary markets.